Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling - Mcdonald, K A; Huang, H; Tohme, S (Mol Med, 2014)
, et al.